| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:67926217:1859 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:67926217:1859?format=raw |
LEADER: 01859fam a2200409 a 4500
001 4056239
005 20221027025355.0
008 970922s1997 ne a b 101 0 eng
010 $a 97041613
020 $a044482782X
035 $a(OCoLC)38220128
035 $a(OCoLC)ocm38220128
035 $9AMX3205HS
035 $a(NNC)4056239
035 $a4056239
040 $aDLC$cDLC$dNNC-M
050 00 $aRC271.R3$bI543 1996
082 00 $a616.99/40642$221
111 2 $aInternational Symposium on Hadrontherapy$n(2nd :$d1996 :$cSwitzerland)
245 10 $aAdvances in hadron therapy :$bproceedings of the Second International Symposium on Hadrontherapy, PSI, and CERN, Switzerland, 9-13 September 1996 /$ceditors, Ugo Amaldi, Börje Larsson, Yves Lemoigne.
246 3 $aAdvances in hadrontherapy
260 $aAmsterdam ;$aNew York :$bElsevier Science B.V.,$c1997.
300 $axxiii, 547 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInternational congress series ;$vno. 1144
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xRadiotherapy$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008100057
650 0 $aHadrons$xTherapeutic use$vCongresses.
650 2 $aNeoplasms.$0https://id.nlm.nih.gov/mesh/D009369
650 2 $aRadiotherapy.$0https://id.nlm.nih.gov/mesh/D011878
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aAmaldi, U.$q(Ugo),$d1934-$0http://id.loc.gov/authorities/names/n86836646
700 1 $aLarsson, Börje.$0http://id.loc.gov/authorities/names/n91127908
700 1 $aLemoigne, Yves.$0http://id.loc.gov/authorities/names/n91046407
830 0 $aInternational congress series ;$vno. 1144.$0http://id.loc.gov/authorities/names/n42029631
852 00 $boff,hsl$hRC271.R3$iI543 1996